Agency: NIH/NIDA
Agency Award Number: Suppl
To examine whether active METH use during the acute phase of HIV infection worsens the depletion of gut-associated lymphocyte tissue (GALT) and therefore increases the risk of micorbial translocation, inflammatory response, and neurocognitive impairment.






